Current best practices and rationalistic perspectives in causation-based prevention, early detection and multidisciplinary treatment of breast and gastric cancer

Gastric & Breast Cancer e-journal
DOI: 10.2122/gbc.2019.0278

EDITORIAL
Advances and challenges of resectable and locally advanced tumors.

Dimitrios Schizas, MD, PhD.

 

Abstract
Advances in the standardization of surgery, chemotherapy and radiotherapy and targeted therapy for a few cancer types have improved oncological outcomes for patients with non-distant metastasis (M0 stage). Based on high-quality evidence from phase III randomized clinical trials (RCT’s) on disease-free survival (DFS) and overall survival (OS) most common tumors are classified into high, moderate, and low aggressiveness cancers. The potential and future perspectives for the development of new therapies and transcriptional heterogeneity are also discussed.

(Citation: Gastric & Breast Cancer 2019; 14(1): 7-13)

Back
You can have an online full-text access and a PDF of this article:
  • Either purchase this paper for €35 EUR. Please, click here
Please specify DOI of article
  • Or through one year subscription PayPal

Online ISSN : 1109 - 7647
Print ISSN : 1109 - 7655

We subscribe to the HONcode principles of the HON Foundation. Click to verify. We subscribe to the HONcode principles. Verify here.
please, read our policy about privacy and confidentiality of information and transparency of sponsorship

last update: 31 May 2019